You are here

CLARAGEN, INC.

Company Information
Address
CLARAGEN, INC. 12300 WASHINGTON AVE, STE 200
ROCKVILLE, MD 20852
United States



Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Recombinant CC10 for treatment of meconium aspiration

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Recombinant human CC 10 is a novel therapeutic agent that is currently in clinical development for prevention of bronchopulmonary dysplasia (BPD) in preterm infant ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  2. Optimum Dose of rhCC10 for Lung Protection in IRDS

    Amount: $99,965.00

    DESCRIPTION (Scanned from the applicant's description): The proposed study involves an evaluation of the dose response to recombinant human CC10 in the preterm lamb, a surfactant-dep ...

    STTRPhase I2001Department of Health and Human Services National Institutes of Health
  3. N/A

    Amount: $0.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health
  4. N/A

    Amount: $749,750.00

    N/A

    SBIRPhase II2000Department of Health and Human Services National Institutes of Health
  5. N/A

    Amount: $99,993.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health
  6. RECOMBINANT HUMAN CC10 FOR PREVENTION OF NEONATAL BPD

    Amount: $97,883.00

    N/A

    SBIRPhase I1998Department of Health and Human Services
US Flag An Official Website of the United States Government